A list of TOP-10 medicines has been published by the volume of sales in the USA. Over the past 25 years, the largest sales volume was recorded for the mega-blockbuster Lipitor, which is not surprising, the drug of Pfizer brought the company 94.67 billion dollars. In the TOP-10 there are also drugs that do not have such status – for example, Epogen.
Analysts of the company IQVIA ranked ten leading drugs in the US for 1992-2017. In addition to Lipitor and Epogen, Plavix entered the rating, which has long been one of the main sources of revenue for Bristol-Myers Squibb and Sanofi. In the first ten, you can also find three immunotherapeutics led by Humira, which is projected to be the first to overcome the bar of annual sales of $ 20 billion.
So, the first three: Lipitor (Pfizer), Humira of AbbVie company, its sales amounted to 75.72 billion dollars and Nexium (AstraZeneca) – 72.45 billion dollars. The fourth is Advair (GSK) – 69.08 billion dollars. The fifth place is held by Enbrel (Amgen) – 67.78 billion dollars. At the sixth Epogen (Amgen) – 55.63 billion dollars, at the seventh Remicade (Johnson & Johnson) – 54.67 billion dollars, the eighth place is held by Abilify (Otsuka / Bristol-Myers Squibb) – 51.34 billion dollars, the ninth is held by Neulasta (Amgen) – 47.40 billion dollars. Plavix (Sanofi / Bristol-Myers Squibb) сloses rating with sales of $ 46.48 billion.